Paper Details

  1. Home
  2. Paper Details

Effects of nebulized sodium cromoglycate on adult patients with severe refractory asthma.

Author: AdachiMitsuru, KiuchiTakahiro, MiyamotoTerumasa, SanoYasuyuki

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study evaluated the efficacy and safety of nebulized sodium cromoglycate in adult patients with severe, refractory asthma. The study found that nebulized sodium cromoglycate was effective in improving morning peak expiratory flow in patients with atopic severe asthma when combined with inhaled corticosteroids.
Paper Details　
Original Abstract of the Article :
Many patients with severe refractory asthma, which is insufficiently controlled by additional high-dose of inhaled corticosteroids, require oral corticosteroids and/or immunosuppressant. Clinicians should seek for suitable medications, for its' chronic use may induce high risk of side effects. The p...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.rmed.2005.06.014

データ提供：米国国立医学図書館（NLM）

Nebulized Sodium Cromoglycate: A Oasis in the Desert of Refractory Asthma

Severe refractory asthma, a persistent and often debilitating condition, can be a challenging foe in the medical desert. This study explores the efficacy of nebulized sodium cromoglycate, a medication known for its anti-inflammatory properties, in treating adult patients with severe asthma. The researchers aimed to evaluate the potential of this medication to improve asthma control and reduce the need for oral corticosteroids.

Finding Relief in the Desert of Asthma

The researchers, like desert explorers seeking a source of relief, found that nebulized sodium cromoglycate, when combined with inhaled corticosteroids, offered significant improvement in lung function for patients with severe atopic asthma. This finding suggests that nebulized sodium cromoglycate holds promise as a potential second-line therapy for severe asthma.

A Breath of Fresh Air in the Desert of Asthma

This research provides a glimmer of hope for patients with severe refractory asthma. By offering an additional treatment option that can effectively control symptoms and reduce the reliance on oral corticosteroids, nebulized sodium cromoglycate may provide a breath of fresh air for those navigating the challenges of this debilitating condition.

Dr.Camel's Conclusion

This study reveals the potential of nebulized sodium cromoglycate as a valuable addition to the treatment arsenal for severe atopic asthma. This research offers a breath of fresh air for patients struggling to manage their symptoms, providing hope for a better quality of life.

Date :
  1. Date Completed 2006-08-29
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

16095893

DOI: Digital Object Identifier

10.1016/j.rmed.2005.06.014

Related Literature

Article Analysis
・Effects of cromolyn oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.